Chromia vs Mira — how do they compare? Chromia trades at Rp239.04 (market cap Rp235,69M, Rp17,87M 24h volume), while Mira trades at Rp700.16 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: Chromia and Mira are close in size by market cap, and Mira's supply is capped (321,5M / 1B MIRA (33%)) while Chromia's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Chromia for 51 Days and Mira for 22 Days on average.
| CHR | MIRA | |
|---|---|---|
Market Cap | Rp235,69M | Rp226,43M |
Volume (24h) | Rp17,87M | Rp101,47M |
Circulating Supply | 988M CHR | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 51 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Chromia (CHR) is currently trading at Rp236.86 with a market cap of Rp232.81 million, showing bearish technical signals overall. The token faces resistance near Rp241-256 while finding support around Rp225-235. With neutral oscillators but bearish moving averages, short-term momentum appears weak. Recent network activity shows average hold time of 51 days, indicating moderate holder confidence despite current price pressure.
Overall outlook remains cautious with key resistance at Rp241 posing immediate challenge. Opportunities exist if token breaks above resistance with volume, while risks include continued bearish momentum testing lower supports. Monitor network adoption metrics and exchange liquidity for directional cues in this volatile crypto environment.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Chromia is a standalone Layer-1 blockchain and EVM compatible Layer-2 enhancement for Binance Smart Chain and Ethereum. It is designed to enhance existing dApps and allow for the creation of next-generation dApps by providing scalability, improved data handling, and customizable fee structures. The blockchain uses a unique architecture called relational blockchain, as well as a custom programming language called Rell.
Read more on CHR →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →